Castelvaccana, Italy

Paolo Barassi


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paolo Barassi

Introduction

Paolo Barassi is an accomplished inventor based in Castelvaccana, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of heart failure. His innovative work has led to the development of unique compounds that have the potential to improve patient outcomes.

Latest Patents

Barassi holds a patent for "Androstane derivatives with activity as pure or predominantly pure stimulators of SERCA2a for the treatment of heart failure." This patent discloses compounds and compositions that activate SERCA2a while only moderately inhibiting the Na/KATPase. The compounds are derivatives of androstane, characterized by a specific formula. Additionally, pharmaceutical compositions comprising these compounds are designed for the treatment of heart failure.

Career Highlights

Paolo Barassi is currently associated with Seismic Pharmaceuticals, where he continues to advance his research and development efforts. His work focuses on creating effective treatments that target heart failure, a condition that affects millions worldwide. His dedication to innovation in this field is evident through his patent and ongoing research.

Collaborations

Barassi collaborates with notable colleagues, including Alberto Cerri and Patrizia Ferrari. Their combined expertise contributes to the success of their projects and enhances the potential impact of their innovations in the pharmaceutical industry.

Conclusion

Paolo Barassi's contributions to the field of pharmaceuticals, particularly through his patent on SERCA2a activators, highlight his role as a key innovator in the treatment of heart failure. His work at Seismic Pharmaceuticals and collaborations with esteemed colleagues further underscore his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…